Nu Skin Enterprises (NYSE:NUS - Get Free Report) is expected to be releasing its Q1 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect Nu Skin Enterprises to post earnings of $0.13 per share for the quarter. Nu Skin Enterprises has set its Q1 2025 guidance at 0.100-0.200 EPS and its FY 2025 guidance at 0.900-1.300 EPS.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.38 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.14. The company had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. Nu Skin Enterprises had a positive return on equity of 5.86% and a negative net margin of 8.46%. On average, analysts expect Nu Skin Enterprises to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Nu Skin Enterprises Stock Performance
Shares of NUS stock traded down $0.24 on Monday, hitting $5.95. 214,172 shares of the stock traded hands, compared to its average volume of 835,329. The company's fifty day moving average is $6.90 and its 200 day moving average is $6.95. Nu Skin Enterprises has a 1-year low of $5.32 and a 1-year high of $14.00. The company has a market capitalization of $296.05 million, a PE ratio of -2.02 and a beta of 1.10. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.82 and a quick ratio of 1.17.
Nu Skin Enterprises Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th were issued a $0.06 dividend. The ex-dividend date was Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 4.03%. Nu Skin Enterprises's dividend payout ratio is currently -8.14%.
Analysts Set New Price Targets
Separately, StockNews.com cut Nu Skin Enterprises from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th.
Read Our Latest Stock Analysis on Nu Skin Enterprises
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
